Go back to Resource Center
Calculated Creatinine Clearance (CCC) as the Most Promising Candidate Surrogate End Point for Clinical Trials
2002
Journal Article
Authors:
Tejani, A.;
Stablein, D.M.;
Ho, P.L.
Location:
Washington D.C.
